- Business
- Jackson Acquisition Company II Jackson Acquisition Company II is a blank check company, or special purpose acquisition company (SPAC), whose primary business is to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses, with a focus on the healthcare services and healthcare technology sectors; it offers investors units comprising one Class A ordinary share and one right to receive one-tenth of a Class A ordinary share upon consummation of an initial business combination. Incorporated in 2024 and headquartered at 2655 Northwinds Parkway in Alpharetta, Georgia, the company operates without significant ongoing business operations prior to completing its targeted transaction, seeking market-leading companies, closely-held businesses, institutionally-backed ventures, or corporate spin-offs in healthcare. Jackson Acquisition Company II completed its initial public offering in December 2024, raising $230 million through the sale of 23 million units at $10.00 per unit on the New York Stock Exchange under the ticker JACS.U, with full exercise of the underwriter's over-allotment option by Roth Capital Partners; in January 2025, it commenced separate trading of its Class A ordinary shares under JACS and rights under JACS.R; led by Chairman and CEO Richard L. Jackson, also of Jackson Healthcare, and CFO David Lawrence, the company maintains a 24-month tenor to identify and execute its business combination.